Retatrutide 30mg

High-purity lyophilized Retatrutide sequence verified via HPLC analysis for high-precision tissue recovery research. Each sterile vial contains 30mg of stabilized powder prepared in a ISO-certified cleanroom.

Description

Retatrutide Canada 30mg – Laboratory Research Reagent

Retatrutide Canada 30mg is supplied as lyophilized material intended for non-clinical laboratory research by qualified facilities and trained personnel.

Product details

• Net content: 30 mg per vial

• Format: Lyophilized material

• Container: 3 mL glass vial

• Intended use

• Non-clinical laboratory research

• Analytical reference and assay development

• Use only in accordance with institutional SOPs and applicable regulatory requirements

• Not for human or animal consumption

• Not for clinical, therapeutic, or diagnostic use

Certificate of Analysis (COA)

Each batch is independently tested and linked to its corresponding documentation. The lot or batch identifier recorded on the vial label can be used to identify the applicable report.

Shipping

• Ships from Ontario, Canada

• Current availability is displayed on this page

Retatrutide Canada 30mg – FAQ

What does “research use only” mean?

This material is supplied exclusively for non-clinical laboratory research and analytical applications. It is not intended for human or animal consumption.

How is batch quality verified?

Batch documentation is published on the product page. The lot or batch identifier recorded on each vial corresponds to the applicable testing documentation.

Where can I review the Certificate of Analysis?

The current batch reports are displayed in the home page title COA.

Does this product ship within Canada?

Yes. Orders are fulfilled from Ontario, Canada. Current availability is shown on this page.